FT. MYERS, Fla.,
Sept. 1, 2011
/PRNewswire/ -- NeoGenomics, Inc. (NASD OTC BB: NGNM)
announced today that it will present at the Rodman & Renshaw Annual Healthcare Investment Conference being held from
September 11-13, 2011
at the Waldorf Astoria Hotel in
New York City
. The conference will showcase small and microcap public healthcare companies. Senior executives of attending companies will make presentations to portfolio managers and analysts on their business strategy and outlook. One-on-one meetings with interested parties will also be arranged during the three-day conference.
NeoGenomics is scheduled to present on
Monday, September 12th
11:15 AM EDT
. A live audio webcast of the presentation can be accessed at
. A PowerPoint presentation and a link to the webcast can also be accessed through the investor relations section of the NeoGenomics website at
at the time of the conference. The webcast will be available for three months.
About NeoGenomics, Inc.
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in
Fort Myers, FL
, NeoGenomics has labs in
and services the needs of pathologists, oncologists, urologists, and hospitals throughout
the United States
. For additional information about NeoGenomics, visit
Interested parties can also access additional investor relations material, including an investment profile and an equity research report, from Hawk Associates at
or from the American Microcap Institute at
SOURCE NeoGenomics, Inc.